Dr Ivana Boljević at UCL Cancer Institute, Department of Cancer Biology gained insights into the ongoing projects at the UCL and learned more about different bioinformatics pipelines, including the analysis of DNA methylation data.
#TRACEPIGEN#PROMIS#fondzanauku
Check out up-to-date overview of the current epidemiological situation concerning lung cancer in Serbia.
Publication: Cavic et al. Lung Cancer in Serbia. Journal of Thoracic Oncology, Volume 17, Issue 7, 867 – 872. https://t.co/2z1wAjjLzJ
Check out up-to-date overview of the current epidemiological situation concerning lung cancer in Serbia.
Publication: Cavic et al. Lung Cancer in Serbia. Journal of Thoracic Oncology, Volume 17, Issue 7, 867 – 872. https://t.co/2z1wAjjLzJ
So happy to announce our work in collaboration with @StephanBeck6 at @uclcancer on benchmarking methods for targeted BS-seq and computational data integration is finally out! :)
@fondzanauku_rs@miljana_21 @MSCActions
https://t.co/Aw2TTyrQjR
For the past three days, we have had a lot of activity. Together with ELBS, @tracepigen and COST Action @transcoloncan we hosted a Liquid Biopsy Training school for 35 participants from all over Europe. Thank you for all the talks, network and discussion #ctDNA#CTC
TRACEPIGEN member Ana Krivokuca participated in the Central-Eastern European Oncology Meets Western-Northern-Southern European Oncology: Clinical Trial Activities International Conference held in Budapest, November 4-5, 2021.
TRACEPIGEN member Milena Cavic received the Best Paper Award at the 20th Central European Lung Cancer Conference organized by the Central European Lung Cancer Association in Vienna, November 11-13, 2021. #PROMIS#tracepigen@CavicMilena
ESMO Clinical Practice Guidelines on Metastatic Non-Small-Cell #LungCancer: Latest update focusing on new treatment recommendations & European Medicines Agency drug approvals w/ relevant #ESMO-MCBS scores https://t.co/LAWTyNFr93 #lcsm#immunotherapy
November is #LungCancerAwarenessMonth! Be aware of the signals your body is sending you and perform regular medical check-ups until a nation-wide screening program for high-risk individuals is launched in Serbia.